Radiomics and artificial intelligence for precision medicine in lung cancer treatment
Seminars in Cancer Biology · 2023-08 · 93 · 97-113
DOI: 10.1016/j.semcancer.2023.05.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-08. Verfasst von Mitchell Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer, The Commonwealth Building, Du Cane Road, Hammersmith Campus, Imperial College, London W12 0NN, UK; Imperial College…. Hauptthemen laut MEDLINE: Artificial Intelligence, Lung Neoplasms. Die Arbeit wurde bisher 212-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Imperial College Healthcare NHS Trust, NIHR Imperial Biomedical Research Centre, NIHR.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths worldwide. It exhibits, at the mesoscopic scale, phenotypic characteristics that are generally indiscernible to the human eye but can be captured non-invasively on medical imaging as radiomic features, which can form a high dimensional data space amenable to machine learning. Radiomic features can be harnessed and used in an artificial intelligence paradigm to risk stratify patients, and predict for histological and molecular findings, and clinical outcome measures, thereby facilitating precision medicine for improving patient care. Compared to tissue sampling-driven approaches, radiomics-based methods are superior for being non-invasive, reproducible, cheaper, and less susceptible to intra-tumoral heterogeneity. This review focuses on the application of radiomics, combined with artificial intelligence, for delivering precision medicine in lung cancer treatment, with discussion centered on pioneering and groundbreaking works, and future research directions in the area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Cancer, The Commonwealth Building, Du Cane Road, Hammersmith Campus, Imperial College, London W12 0NN, UK; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12…
- North West London Pathology, Charing Cross Hospital, Fulham Palace Rd, London W6 8RF, UK.
- Department of Surgery and Cancer, The Commonwealth Building, Du Cane Road, Hammersmith Campus, Imperial College, London W12 0NN, UK.
- Department of Surgery and Cancer, The Commonwealth Building, Du Cane Road, Hammersmith Campus, Imperial College, London W12 0NN, UK. Electronic address: eric.aboagye@imperial.ac.uk.
Förderung
- Imperial College Healthcare NHS Trust
- NIHR Imperial Biomedical Research Centre
- NIHR
- Academy of Medical Sciences
Zitieren
APA
Chen, M., Copley, S. J., Viola, P., Lu, H., & Aboagye, E. O. (2023). Radiomics and artificial intelligence for precision medicine in lung cancer treatment. Seminars in Cancer Biology, 93, 97-113. https://doi.org/10.1016/j.semcancer.2023.05.004
Vancouver
Chen M, Copley SJ, Viola P, Lu H, Aboagye EO. Radiomics and artificial intelligence for precision medicine in lung cancer treatment. Seminars in Cancer Biology. 2023;93:97-113. doi:10.1016/j.semcancer.2023.05.004
BibTeX
@article{Chen2023,
author = {Chen, Mitchell and Copley, Susan J and Viola, Patrizia and Lu, Haonan and Aboagye, Eric O},
title = {Radiomics and artificial intelligence for precision medicine in lung cancer treatment},
journal = {Seminars in Cancer Biology},
year = {2023},
volume = {93},
pages = {97--113},
doi = {10.1016/j.semcancer.2023.05.004}
}
EUVIMED